A three-dimensional high-performance liquid chromatography (HPLC) method is described for the determination of cyclosporine A in human skin. The method allows to determine at least 3 ng cyclosporine A in 10 mg skin (total sample amount needed) and is suitable for cyclosporine A level monitoring in the skin of psoriatic patients.
The purpose of this work was to develop an analytical method that would enable to investigate the relationship between the skin CyA level and the antipsoriatic effect by oral CyA application. To reduce the stress of the patients, the amount of skin sample should not exceed 10-20 mg.
Several methods of CyA determination in biological material were published, mostly based on HPLC or radioimmunoassay, but only few of them were used for skin analysis 1,2 ' 3 ' 4 ). All these methods are of relatively low sensitivity and require large sample amounts (about 100 mg).
The CyA skin level was found to be approximately 3.5 ng/mg wet weight by patients receiving a daily oral dose of 14 mg/kg 4) . However, the common therapeutical doses are smaller; provided in such case the CyA level is equal to or less than 1 ng/mg tissue, the sensitivity required for the determination would be 10 ng CyA/sample and less.
Preliminary solid-phase extraction experiments on the 10 ng level failed. The skin extract purification step using common SPE procedures was not successful due to partially irreversible adsorption of the CyA on the cartridge. Several sorbents were used but the recovery was not reproducible and mostly less than 50%. Only the multi-dimensional HPLC provided the required results. The samples were handled in 4 ml screwing cap vials with PTFE seal.
Materials and Methods

Reagents and purity requirements
All used glass was cleaned with chromosulfuric acid. N 2 used for sample evaporation was of 5.0 quality with an all-steel pressure degradation vent.
Skin extraction
Skin used for recovery experiments originated from amputation. After separation it was frozen and then handled in two ways: a) An approximately 0.5 mm thick upper layer was taken by lancet.
b) The epidermis only (0.2 mm) was separated by a microtome; the separation was controlled by microscopy.
10-15 mg skin sample and approximately 100 mg quartz sand p.a. were placed in a small mortar, cooled with liquid N 2 and homogenized after its evaporation. The mortar was let to warm up and the sample was further homogenized with 1 ml CH 3 CN. For recovery experiments 10 ul CyA stock solution were added with this first CH 3 CN portion. The homogenate was transferred into a 4 ml vial using Pasteur pipette, the vial was centrifuged at 1000 g for 3 min. The supernatant was transferred using another Pasteur pipette into a 5 ml PE syringe and immediately passed through a 0.2 urn filter into a scaled 10 ml centrifuge tube.
Mortar and pestle were washed with 1 ml CH 3 CN, the liquid was transferred to the sediment and the vial was vortexed for 30 s and centrifuged for 3 min at 1000 g. The supernatant was filtered into the centrifuge tube and the wash step was repeated using sonication instead of vortexing.
The combined filtrate was evaporated on a 50°C water bath by a N 2 stream to 0.3 ml volume, and by slow vortexing 0.9 ml water were added; the sample became slightly opalescent. 
Sample collection
The CyA analytical window was checked by injection of a mixture of approximately 100 ul CyA stock solution + 0.2 ml CH 3 CN + 0.9 ml H 2 0 + 0.2 ml mobile phase. Sample analysis was done with an identical mobile phase. The sample was filled into the injector loop and the centrifugation tube was washed with 0.2 ml mobile phase, shortly vortexed with maximal intensity, and shortly centrifuged. The washing liquid was also filled into the injector loop and the whole sample was injected. In the CyA elution interval the trap was switched on.
Trap handling
After sampling has been completed, the trap was washed with 1 ml H 2 0, approx. 1 min blown with N 2 and eluted in the opposite direction with 0.5 ml CH 3 CN. The effluent was evaporated to dryness on a water bath at 50°C with a N 2 stream. It was usefull to continue the N 2 -blowing for further 10 min so that the amount of volatile contaminants originated from CH 3 CN was reduced. The CyA recovery was not affected thereby. The residue was analysed by RP-HPLC.
Column and trap washing
After analysis the preparative column was washed at 75°C in the opposite direction together with the cleaning column at room temp, successively with 50 ml CH 3 CN, 50 ml CH 3 CN-H 2 0 1:1 with NaOH addition up to 0.2 mmol NaOH total concentration, and 50 ml CH 3 CN. The trap was washed in the opposite direction at room temp, with 50 ml CH 3 CN and 0. 
Sample analysis
The sample residue of the preparative collection was reconstituted analogously to the standard. During its analysis on the RP-HPLC analytical column the detector effluent was collected in the interval of the CyA analytical window, 10 pi CyC stock solution were added, and the effluent was immediately evaporated to dryness on a water bath at 50°C by a N 2 stream.
The residue was reanalysed in the following step. 
Normal-phase HPLC
Results and Discussion
Both analytical and the preparative column were maintained at 70-75°C in order to accelerate the interconversion of the CyA conformers 5) and so to prevent peak broadening.
Preparative HPLC
The presented procedure requires a high degree of purity of all solvents and materials especially on account of working with a trap. CH 3 CN of various qualities and of various origins was checked for impurities. In all lots three contaminants were found which, however, did not interfere with CyA. LiChrosolv water contained only a small quantity of a substance eluted in the CyA vicinity. By preparative HPLC it was possible to remove most of the mentioned contaminants using a short cleaning PRP-1 pre-column connected to the pump outlet.
Most of the skin matrix substances were found to be of acidic character. On a preparative octadecylsilane column with an acidic mobile phase they were strongly retained and the peaks were tailing as compared to neutral conditions. In these both cases, however, the CyA peak was overlapped by the skin matrix peaks. Only the application of an alkaline mobile phase and an alkaline-resistant sorbent (PRP-1 or Spherisorb Alumina PC-18) enabled the required separation (Fig. 2) .
The preparative chromatography of the skin matrix was satisfactory provided only upper skin layer (epidermis and dermis) were taken. By analysis of the samples containing deeper skin layers or subcutaneous tissue the separation was not reliable and relative large peaks appeared in the CyA window (probably lipids). 
Reversed-phase HPLC
Typical chromatograms obtained from CyA spiked skin and a sample from a psoriatic patient are shown in Fig. 3 .
If the CyA analytical window and its vicinity are free of interfering peaks CyA can be determined down to concentration of 0.5 ng using CyC as an internal standard. However, in some separations of thicker upper skin layers taken by lancet the result can be affected by fusion of the internal standard peak with some relative great impurity peaks. Because CyA recovery was almost quantitative in the given case the external standard method seems to be just as reliable.
The recovery was extensively checked on the 10 ng level: it amounts to 101.3% (mean of 3 determinations, RSD 1.1%) without skin addition and 96.8% (mean of 6 determinations, RSD 6.3%) by the complete analysis of spiked skin samples.
The sensitivity of the analytical RP-HPLC was relatively high. By injection of 0.94 ng CyA the signal/noise ratio was 27. It should be theoretically possible to determine less than 367 0.5 ng CyA, if all the substances out of the skin matrix could be removed in a nearly quantitative way. Otherwise the 3 ng CyA/sample must be considered as the lowest limit for reliable determination.
This work was done in cooperation with the Department of Dermatology of the University of Cologne; three skin samples were supplied taken by biopsy from psoriatic patients. A CyA content was found therein from 1 to 6 ng/mg wet tissue. 
Normal-phase HPLC
When the skin matrix separation by preparative HPLC was insufficient and, therefore, the RP-HPLC determination was not reliable, it was possible to carry out an additional analysis with the collected CyA-effluent out of the RP-HPLC column by its reinjection (after proper treatment) into the normal-phase HPLC system 6) . Preliminary experiments using a cyanopropylsilica column and 10% isopropanol in hexan as mobile phase gave promissing results.
Five standard analyses were carried out to prove the recovery of this step: each time 10 |il of CyA and CyC stock solutions were mixed with approximately 2 ml mobile phase collected behind the analytical RP-HPLC column and this simulated effluent was treated previous to injection like a true sample.
The recoveries of both cyclosporines ranged approximately from 75% to 90% compared to the direct standard injections of the same amounts of CyA and CyC in 15% iPrOH/hexane but the peak areas ratio CyA/CyC was constant (mean 1.022, RSD 4.3%), which made the internal standard method usable. Quantitative recoveries were achieved using fresh 2 ml RP-HPLC analytical mobile phase instead of the one collected behind the column. At 75°C the surface of the modified silica is relatively strongly degraded and the released octadecylsilanol molecules create a hydrophobic cover on the glass wall, which can bind cyclosporine.
Three complete spiked skin analyses including all three HPLC steps were performed with satisfactory results. CyA amounts calculated on the base of the normal-phase HPLC ranged from 94% to 103% (mean 99.3%, RSD 4.8%). Analytical chromatograms of one of these analyses are shown in the Fig. 3 .
